HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa

HIV/AIDS - Research and Palliative Care

Volumn 4, Issue , 2012, Pages 1-4

  Mamadou, Saïdou ^a,b   Ide, Moussa ^c   Ali Maazou, Amadou Roufaï ^b   Aoula, Balki ^b   Labo, Seyni ^d   Bozari, Mamane ^d  

^a UNIVERSITÉ ABDOU MOUMOUNI   (Niger)

^b National Reference Laboratory for STI/HIV/TB   (Niger)

^c Inter Sectorial Program on STI/HIV/AIDS   (Niger)

^d National Center for Social Sciences Expertise   (Niger)

Author keywords

HBV; HIV; Niger; Pregnant women; Seroprevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AFRICA; AGE; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD TRANSFUSION; EDUCATION; ENVIRONMENT; FEMALE; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MARRIAGE; MIXED INFECTION; PREGNANT WOMAN; REPRODUCTIVE HEALTH; SEROPREVALENCE; VERTICAL TRANSMISSION; WEST AFRICA;

EID: 84857088438     PISSN: None     EISSN: 11791373     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2009 AIDS Epidemic Update. Geneva, Switzerland: UNAIDS and World Health Organization. Available from: http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/report/2009/jc1700_epi_update_2009_en.pdf. Accessed November 27, 2011.
2. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337(24): 1733-1745.
3. Brechot C, Pourcel C, Louise A, et al. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 1980;286(5772):533-535.
4. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981;2(8256):1129-1133.
5. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley and Sons 1981;14-15.
6. Boisier P, Ouwe Missi Oukem-Boyer ON, Amadou HA, et al. Nationwide HIV prevalence survey in general population in Niger. Trop Med Int Health. 2004;9(11):1161-1166.
7. Mamadou S, Cisse RM, Ali MAR, et al. Séroprévalence de l'infection à VIH en population générale au Niger en 2006 [HIV infection seroprevalence in general population in Niger in 2006]. Annales de l'Université Abdou Moumouni. 2010;11(Tome XI-A):20-23. [French.]
8. Tohon Z, Mamadou S, Mainassara HB, et al. HIV seroprevalence surveys in Nigerien pregnant women: a comparison between 2002 and 2006. Trans R Soc Trop Med Hyg. 2007;101(11):1101-1105.
9. Ousseini H, Pecarrere JL, Meynard D, et al. Evolution de la séroprévalence des infections à VIH1 et VIH2 à l'Hôpital National de Niamey, Niger [Evolution of the seroprevalence of HIV-1 and HIV-2 infections in the national hospital of Niamey, Niger]. Bull Soc Pathol Exot. 1991;84(3):235-239. [French.]
10. Marlink R. Lessons from the second AIDS virus, HIV-2. AIDS. 1996; 10(7):689-699.
11. Jongerius JM, Wester M, Cuypers HT, et al. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion. 1998;38(1):56-59.
12. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2(8):479-486.
13. Soubiran G, Le Bras M, Marini P, et al. High HBsAg and anti-delta carrier rate among asymptomatic Africans living on the campus of the University of Niamey, Niger. Trans R Soc Trop Med Hyg. 1987;81(6): 998-1000.
14. Mamadou S, Idé M, Gagara H, et al. Séroprévalence des hépatites B et C chez les personnes vivant avec le VIH au Niger [Hepatitis B and C seroprevalence among people living with HIV/AIDS in Niger]. Journal de la Société de Biologie Clinique. 2009;013:42-44. [French.]
15. Mamadou S, Rabo S, Ali Maazou AR, et al. Séroprévalence des virus de l'immunodéficience humaine, des hépatites B et C chez les donneurs de sang de Niamey en 2007 [HIV infection, hepatitis B and C seroprevalence among blood donors of Niamey in 2007]. Annales de l'Université Abdou Moumouni. 2010;11(Tome A):28-31. [French.]